Kymera Therapeutics Company
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Connections from
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Technology:
Others
Founded Date:
2017
Industry:
PharmTech